{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:14:17Z","timestamp":1779905657728,"version":"3.53.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T00:00:00Z","timestamp":1349222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10067-012-2098-x","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T04:47:13Z","timestamp":1349153233000},"page":"181-188","source":"Crossref","is-referenced-by-count":27,"title":["Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review"],"prefix":"10.1007","volume":"32","author":[{"given":"Sigong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,3]]},"reference":[{"issue":"2","key":"2098_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","volume":"81","author":"E Arioglu","year":"2002","unstructured":"Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P (2002) Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine (Baltimore) 81(2):87\u2013100","journal-title":"Medicine (Baltimore)"},{"key":"2098_CR2","first-page":"123","volume-title":"Insulin resistance","author":"P Gorden","year":"1993","unstructured":"Gorden P, Collier E, Roach P (1993) Autoimmune mechanisms of insulin resistance and hypoglycemia. In: Moley DE (ed) Insulin resistance. Wiley, London, pp 123\u2013142"},{"key":"2098_CR3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1210\/jc.74.6.1242","volume":"74","author":"PM Sluss","year":"1992","unstructured":"Sluss PM, Schneyer AL (1992) Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients. J Clin Endocrinol Metab 74:1242\u20131246","journal-title":"J Clin Endocrinol Metab"},{"key":"2098_CR4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/diabetes.33.3.301","volume":"33","author":"R Pirro De","year":"1984","unstructured":"De Pirro R, Roth RA, Rossetti L, Goldfine ID (1984) Characterization of the serum from a patient with insulin resistance and hypoglycemia. Evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities. Diabetes 33:301\u2013304","journal-title":"Diabetes"},{"key":"2098_CR5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1210\/jcem-73-3-650","volume":"73","author":"S Paolo Di","year":"1991","unstructured":"Di Paolo S, Giorgino R (1991) Insulin resistance and hypoglycemia in a patient with systemic lupus erythematosus: description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action. J Clin Endocrinol Metab 73:650\u2013657","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2098_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2337\/dc10-0488","volume":"34","author":"X Qi","year":"2011","unstructured":"Qi X, Sun J, Wang J, Wang PP, Xu Z, Murphy M, Jia J, Wang J, Xie Y, Xu W (2011) Prevalence and correlates of latent autoimmune diabetes in adults in Tianjin, China: a population-based cross-sectional study. Diabetes Care 34(1):66\u201370","journal-title":"Diabetes Care"},{"issue":"3","key":"2098_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MD.0b013e3181a5b42e","volume":"88","author":"BC Lupsa","year":"2009","unstructured":"Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P (2009) Autoimmune forms of hypoglycemia. Medicine (Baltimore) 88(3):141\u2013153","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"2098_CR8","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1210\/jc.2010-0167","volume":"95","author":"R Malek","year":"2010","unstructured":"Malek R, Chong AY, Lupsa BC, Cochran EK, Soos MA, Semple RK, Balow JE, Gorden P (2010) Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies. J Clin Endocrinol Metab 95(8):3641\u20133647","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2098_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00592-011-0271-3","volume":"49","author":"KH Joung","year":"2012","unstructured":"Joung KH, Kim HJ, Ku BJ (2012) Type B insulin resistance syndrome with diabetic ketoacidosis. Acta Diabetol 49(1):81\u201382","journal-title":"Acta Diabetol"},{"issue":"6","key":"2098_CR10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1464-5491.2005.01529.x","volume":"22","author":"AP Coll","year":"2005","unstructured":"Coll AP, Morganstein D, Jayne D, Soos MA, O\u2019Rahilly S, Burke J (2005) Successful treatment of type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus. Diabet Med 22(6):814\u2013815","journal-title":"Diabet Med"},{"issue":"12","key":"2098_CR11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ncpendmet0693","volume":"3","author":"KA Page","year":"2007","unstructured":"Page KA, Dejardin S, Kahn CR, Kulkarni RN, Herold KC, Inzucchi SE (2007) A patient with type B insulin resistance syndrome, responsive to immune therapy. Nat Clin Pract Endocrinol Metab 3(12):835\u2013840","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"8","key":"2098_CR12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2337\/diacare.21.8.1217","volume":"21","author":"JW Eriksson","year":"1998","unstructured":"Eriksson JW, Bremell T, Eliasson B, Fowelin J, Fredriksson L, Yu ZW (1998) Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report. Diabetes Care 21(8):1217\u20131220","journal-title":"Diabetes Care"},{"issue":"3","key":"2098_CR13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM200401153500324","volume":"350","author":"AP Coll","year":"2004","unstructured":"Coll AP, Thomas S, Mufti GJ (2004) Rituximab therapy for the type B syndrome of severe insulin resistance. N Engl J Med 350(3):310\u2013311","journal-title":"N Engl J Med"},{"issue":"3","key":"2098_CR14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5694\/j.1326-5377.2009.tb02335.x","volume":"190","author":"HA Tran","year":"2009","unstructured":"Tran HA, Reeves GE (2009) Treatment of type B insulin resistance with immunoglobulin: novel use of an old therapy. Med J Aust 190(3):168","journal-title":"Med J Aust"},{"issue":"4","key":"2098_CR15","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.10879","volume":"48","author":"A Gehi","year":"2003","unstructured":"Gehi A, Webb A, Nolte M, Davis J Jr (2003) Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil. Arthritis Rheum 48(4):1067\u20131070","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2098_CR16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.metabol.2006.12.016","volume":"56","author":"GG Fareau","year":"2007","unstructured":"Fareau GG, Maldonado M, Oral E, Balasubramanyam A (2007) Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome. Metabolism 56(5):670\u2013675","journal-title":"Metabolism"},{"issue":"2","key":"2098_CR17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5414\/CNP69130","volume":"69","author":"Y Nagayama","year":"2008","unstructured":"Nagayama Y, Morita H, Komukai D, Watanabe S, Yoshimura A (2008) Type B insulin resistance syndrome induced by increased activity of systemic lupus erythematosus in a hemodialysis patient. Clin Nephrol 69(2):130\u2013134","journal-title":"Clin Nephrol"},{"issue":"2","key":"2098_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4158\/EP.15.2.153","volume":"15","author":"AL Daniel","year":"2009","unstructured":"Daniel AL, Houlihan JL, Blum JS, Walsh JP (2009) Type B insulin resistance developing during interferon-alpha therapy. Endocr Pract 15(2):153\u2013157","journal-title":"Endocr Pract"},{"issue":"2","key":"2098_CR19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1756-185X.2009.01402.x","volume":"12","author":"V Ostwal","year":"2009","unstructured":"Ostwal V, Oak J (2009) Type B insulin resistance in a systemic lupus erythematosus patient. Int J Rheum Dis 12(2):174\u2013176","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"2098_CR20","first-page":"299","volume":"86","author":"KH Jeong","year":"2010","unstructured":"Jeong KH, Oh SJ, Chon S, Lee MH (2010) Generalized acanthosis nigricans related to type B insulin resistance syndrome: a case report. Cutis 86(6):299\u2013302","journal-title":"Cutis"},{"issue":"4","key":"2098_CR21","doi-asserted-by":"crossref","first-page":"E653","DOI":"10.1210\/jc.2010-1949","volume":"96","author":"K Mohammedi","year":"2011","unstructured":"Mohammedi K, Roussel R, El Dbouni O, Potier L, Abi Khalil C, Capel E, Vigouroux C, Caron-Debarle M, Capeau J, Marre M (2011) Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman. J Clin Endocrinol Metab 96(4):E653\u2013E657","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2098_CR22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5414\/CNP73157","volume":"73","author":"N Sato","year":"2010","unstructured":"Sato N, Ohsawa I, Takagi M, Gohda T, Horikoshi S, Shirato I, Yamaguchi Y, Tomino Y (2010) Type B insulin resistance syndrome with systemic lupus erythematosus. Clin Nephrol 73(2):157\u2013162","journal-title":"Clin Nephrol"},{"issue":"5","key":"2098_CR23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2169\/internalmedicine.49.2746","volume":"49","author":"SY Kawashiri","year":"2010","unstructured":"Kawashiri SY, Kawakami A, Fujikawa K, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Origuchi T, Ida H, Eguchi K (2010) Type B insulin resistance complicated with systemic lupus erythematosus. Intern Med 49(5):487\u2013490","journal-title":"Intern Med"},{"issue":"1","key":"2098_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4158\/EP.13.1.51","volume":"13","author":"S Bao","year":"2007","unstructured":"Bao S, Root C, Jagasia S (2007) Type B insulin resistance syndrome associated with systemic lupus erythematosus. Endocr Pract 13(1):51\u201355","journal-title":"Endocr Pract"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2098-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-012-2098-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2098-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T11:11:59Z","timestamp":1594725119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-012-2098-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2098-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,3]]}}}